A week ago, the Biden administration announced support for waiving intellectual property protection for Covid-19 vaccines. In response, Bio, a trade association representing biotechnology companies, issued a statement saying, "The United States has unfortunately chosen to set a dangerous precedent with these actions.” This week on Intercepted: Intercept investigative journalists Sharon Lerner and Lee Fang discuss how the pharmaceutical industry has ruthlessly fought to maintain IP protection from the beginning of the pandemic despite global calls to share knowledge and know-how to end the crisis as quickly as possible. By claiming the same monopoly IP rights on Covid-19 therapeutics and vaccines as other drugs, the industry has perpetuated a market of scarcity and profiteering when a collaborative global response is needed.
 See acast.com/privacy for privacy and opt-out information.